Bifogade filer
Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Xbrane Biopharma via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
2020-08-20 13:30:00
Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on August 21, 2020, at 10.00 a.m. CET. Xbrane will publish the company’s interim report January – June 2020, on Friday August 21, 2020, at 8.00 a.m. CET.
Martin Åmark, CEO, and Susanna Helgesen, CFO, will present Xbrane and comment on the interim report January – June 2020, followed by a Q&A session. The presentation will be in English. To attend, please dial-in at one of the numbers below:
Standard international: +44 (0) 2071 928 338
UK (Local): +44 (0) 844 481 97 52
UK (Tollfree): 08 002 796 619
Sweden (Local): +46 (0) 850 692 180
Sweden (Toll Free): 020 012 51 60
US (LocaL): +1 646 741 31 67
US (Toll Freee): +1 877 870 91 35
Confirmation Code: 4598698